CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 28 enrolled
Drug / intervention
Lidocaine geldrug
Likely dose
Lidocaine gel 75 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04167189
NCT04167189Early Ph 1Completed
CompareCT.gov

Prevalence of Lidocaine Ineffectiveness in Those With Hard-to-treat ADHD

PhenoSolve, LLC·interventional·Posted Nov 18, 2019·Updated Jul 2, 2021

In Brief

A Early Phase 1 clinical trial evaluating Lidocaine gel for ADHD. Completed, enrolled 28 participants across 1 site.

Detailed Summary

This work will assess the prevalence in hard-to-treat ADHD of the ineffectiveness of the anesthetic Lidocaine.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsADHD
CountriesUnited States
CollaboratorsNeurAbilities (formerly CRCNJ)

Timeline

Early Ph 1CompletedFinished
201820192020202120222023202420252026
First PostedNov 18, 2019
Enrollment StartJan 20, 2018
Primary CompletionMar 30, 2020
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 6.6 years ago

Interventions

Lidocaine geldrug

Septodont 5% oral lidocaine gel (NDC 0362-0221-10), 75 mg